HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Number of Harvested LNs Is an Independent Prognostic Factor in Lymph Node Metastasis-negative Patients Who Received Curative Esophagectomy.

AbstractBACKGROUND/AIM:
The aim of the present study was to evaluate the optimal number of harvested LNs (LNs) in patients who were LN metastasis-negative after curative esophagectomy for esophageal cancer.
PATIENTS AND METHODS:
Sixty-one patients who underwent curative surgery for esophageal cancer between 2005 and 2017 and diagnosed as lymph node metastasis-negative were included in this study.
RESULTS:
The 5-year overall survival rates were 27.8% for 0-20 harvested LNs, 35.7% for 21-30 harvested LNs, 79.4% for 31-40 harvested LNs, and 85.2% for ≥41 harvested LNs. Thirty harvested LNs was regarded as the optimal critical point of classification, considering the 5-year OS rate. The number of harvested LNs was selected as a significant prognostic factor in both univariate and multivariate analyses. The respective 3- and 5-year OS rates were 50.3% and 36.7% for <30 harvested LNs and 82.4% and 82.4% for ≥30 harvested LNs (p=0.003).
CONCLUSION:
Thirty or more harvested LNs was a significant prognostic factor in patients with metastasis-negative LNs after curative esophagectomy for esophageal cancer. Therefore, the number of harvested LNs might be useful for predicting the LN metastasis status in esophageal cancer.
AuthorsToru Aoyama, Yosuke Atsumi, Shinnosuke Kawahara, Hiroshi Tamagawa, Ayako Tamagawa, Yukio Maezawa, Kazuki Kano, Masaaki Murakawa, Keisuke Kazama, Masakatsu Numata, Takashi Oshima, Norio Yukawa, Munetaka Masuda, Yasushi Rino
JournalIn vivo (Athens, Greece) (In Vivo) 2020 Jul-Aug Vol. 34 Issue 4 Pg. 2021-2027 ISSN: 1791-7549 [Electronic] Greece
PMID32606176 (Publication Type: Journal Article)
CopyrightCopyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Topics
  • Esophageal Neoplasms (pathology, surgery)
  • Esophagectomy
  • Humans
  • Lymph Node Excision
  • Lymph Nodes (pathology, surgery)
  • Lymphatic Metastasis
  • Neoplasm Staging
  • Prognosis
  • Retrospective Studies
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: